RAFFA WEALTH MANAGEMENT, LLC’s Nektar Therapeutics NKTR Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	-$23	–	1082
2023 Q1	$23	Hold	2	–	–	﹤0.01%	1070
2022 Q4	$75	Hold	2	–	–	﹤0.01%	1057
2022 Q3	$106	Hold	2	–	–	﹤0.01%	1153
2022 Q2	$125	Hold	2	–	–	﹤0.01%	1121
2022 Q1	$178	Hold	2	–	–	﹤0.01%	1124
2021 Q4	$446	Hold	2	–	–	﹤0.01%	1069
2021 Q3	$593	Hold	2	–	–	﹤0.01%	1004
2021 Q2	$566	Hold	2	–	–	﹤0.01%	1023
2021 Q1	$660	Hold	2	–	–	﹤0.01%	986
2020 Q4	$561	Hold	2	–	–	﹤0.01%	849
2020 Q3	$547	Hold	2	–	–	﹤0.01%	794
2020 Q2	$764	Hold	2	–	–	﹤0.01%	729
2020 Q1	$589	Hold	2	–	–	﹤0.01%	717
2019 Q4	$712	Buy	2 +1	+100%	+$290	﹤0.01%	695
2019 Q3	$310	Buy	+1	New	+$367	﹤0.01%	739
2019 Q2	–	Sell	-1	Closed	-$571	–	1166
2019 Q1	$571	Hold	1	–	–	﹤0.01%	704
2018 Q4	$559	Hold	1	–	–	﹤0.01%	715
2018 Q3	$1.04K	Hold	1	–	–	﹤0.01%	593
2018 Q2	$830	Hold	1	–	–	﹤0.01%	685
2018 Q1	$1.81K	Buy	+1	New	+$1.29K	﹤0.01%	381

Other funds holding NKTR

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's NKTR Position: Q2 2023 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 2 shares — an estimated $23 sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in NKTR in Q1 2018 and held it in 20 quarters. The position peaked at $1.81K in Q1 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 2 Nektar Therapeutics shares in Q2 2023, an estimated $23.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Nektar Therapeutics in Q1 2018 and held it in 20 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Nektar Therapeutics position peaked at $1.81K in Q1 2018.
146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2023, filed 27 Jul 2026.